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We  have  previously  described  the  genetically  determined  resistance  to  several 
orthomyxoviruses  in  mice carrying  a  dominant  gene,  Mx  (1).  Resistance  was  also 
expressed  in  in  vitro  cultures  of the  resistant  mouse  peritoneal  macrophages  (2). 
Several attempts to overcome resistance in vivo or in vitro have failed; these included 
whole  body  x-irradiation,  neonatal  thymectomy,  treatments  with  cortisone,  cyclo- 
phosphamide,  methotrexate,  thorotrast,  silica  (3,  4),  and  radioactive strontium  (O. 
Haller, unpublished observations), as well as introduction of the gene Mx into athymic 
mice  (5).  The  availability of potent  antiserum  prepared  against  partially  purified 
mouse interferon (6) permitted us to determine the role of interferon in this resistance. 
A priori, this did not seem likely because resistance was highly specific for a group of 
closely related viruses, whereas interferon  is not thought  to be virus specific. Never- 
theless, the use of anti-interferon serum had proven useful in showing that interferon 
was part of the resistance of C3H and A/J mice to mouse hepatitis virus-3 (7).  In the 
experiments to be presented  herein,  it was found that small amounts of sheep anti- 
mouse interferon globulin (AIF) 1 rendered genetically resistant mice fully susceptible 
to  the  lethal  effect of influenza  virus,  and  virus  titers  in  such  mice reached  levels 
similar to those observed in genetically susceptible animals. We conclude  therefore, 
that interferon is an important component of the genetically determined resistance to 
influenza virus in some strains of mice. 
Materials and Methods 
Mice.  A/J mice were purchased  from G1.  Bomholtg~.rd  Ltd.,  Ry, Denmark.  Inbred  A2G 
mice (genetically  Mx/Mx)  (1) and crosses (A2G  ×  A/J)F1 were bred locally as described (2). 
Adult animals of both sexes were used. 
Viruses.  The following avian influenza A virus strains derived from A/Turkey/England/63 
(Havl, Nav3;  Langham strain)  (8)  were used:  (a)  M-TUR was adapated to grow  in mouse 
* Supported by the Swiss National Science Foundation, grant 3.139-0.77 and Directions des R~cherches 
et ]~tudes Techniques (77/203). 
1  Abbreviations used in this paper: ACN, globulin directed against contaminants of mouse interferon; AHI, 
anti-human  interferon globulin; AIF, anti-mouse interferon globulin; CPE, cytopathic effect;  FCS, fetal 
calf serum;  HA, hemagglutination;  HAI, hemagglutination  inhibition;  HKH,  influenza virus  A/Hong 
Kong/1/68;  i.e., intracerebral;  i.n.,  intranasal;  i.p.,  intraperitoneal;  i.v., intravenous; LDs0, mean lethal 
dose;  M-TUR, macrophage adapted  influenza virus  A/Turkey/England/63;  NSG, normal sheep  serum 
globulin; PBS, phosphate buffered saline; TCIDs0, mean tissue culture infective dose; TURH, hepatotropic 
influenza virus A/Turkey/England/63. 
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peritoneal macrophages in vitro (2).  Stock virus grown in  10-d-old embryonated eggs had a 
hemagglutination (HA)  titer of  1:640 and contained  l0  s mean tissue culture infective doses 
(TCIDs0)/ml as determined by titrations in susceptible A/J  macrophages.  (b)  TURH was  a 
hepatotropic variant causing acute liver necrosis and death within 3-4 d in normal adult mice 
(9).  Egg-grown stocks with a  HA titer of 1:16 contained 106.7 mean lethal doses (LDso)/ml as 
estimated by intraperitoneal (i.p.) titration in susceptible A/J mice. The Stuart-Harris strain of 
neurotropic influenza A virus, NWS (H0 N~) (10), was used as a  10% A/J brain extract (2). The 
human influenza strain HKH, A/Hong-Kong/1/68 (H3  N2),  had undergone 132  passages in 
mouse lung and was kept as 10% A/J lung extract  (I 1). 
Virus Titrations.  These were  done by standard procedures  (1).  Infectivity of TURH  was 
titrated by intra-allantoic inoculation of serial 10-fold virus dilutions into 10-d-old embryonated 
eggs or by i.p. titrations in adult A/J mice. M-TUR was titrated in cultured A/J macrophages. 
HKH was assayed by intranasal (i.n.), NWS by intracerebral (i.c.)  titrations in adult A/J mice. 
Hemagglutinin and hemagglutination inhibition (HAI) titers were  measured by the pattern 
method  in  World  Health  Organization  hemagglutination trays.  Standard  rabbit  antisera 
prepared several years earlier against HKH, NWS, or A/Turkey/England/63 were repeatedly 
used in HAI tests to check the identity of the viruses. 
Media.  Culture medium consisted of RPMI  1640 with L-glutamine (Gibco, Biocuh, Glas- 
gow, Scotland) supplemented with 30%  or  15% fetal calf serum (FCS)  (Gibco, batch selected 
for  low  content  of virus  inhibitors), penicillin (100  U/ml),  and  streptomycin  (100  ~g/ml). 
Phosphate-buffered  saline  (PBS)  contained  8.0  g  NaCI,  2.7  g  Na2HPO4.7H20  and  0.4  g 
K~PO4/liter. 
Macrophage Cultures.  These  were  prepared  as  previously described  in  detail  (2).  Briefly, 
peritoneal macrophages from mice stimulated 3 d previously by 2-ml i.p. injections of thiogly- 
collate medium (Difco Laboratories, Detroit, Mich.) were harvested, washed, and counted in a 
hemocytometer.  5  ×  106 viable cells in 2  ml of culture medium containing 30%  FCS were 
plated into 35-mm diameter wells of FB-6-TC disposable six-well tissue culture trays (Linbro 
Chemical Co., Hamden, Conn.). After 3-4 h  of incubation at 37°C in a  moist atmosphere of 
5% CO2 in air, all cells not firmly attached to the plastic bottom of the wells were resuspended 
by repeated  pipetting and were discarded.  2 ml of fresh culture medium supplemented with 
30% FCS were added to the adherent cells which were further incubated for 16-18 h. Adherent 
cells were then washed again and refed with 1.8 ml of fresh medium containing 15% FCS; they 
were now ready for treatment with globulin preparations and/or for virus challenge. 
Virus Challenge of Macrophages.  0.2 ml of  10-fold dilutions of M-TUR in culture medium 
containing 15% FCS were added to each well to give the desired virus input dose as stated in 
the text. At various times thereafter,  the wells were inspected with an inverse phase-contrast 
microscope  (X  40  objective).  The  occurrence  of a  cytopathic  effect  (CPE)  was  scored  by 
comparison  with  uninfected control wells.  At  the  same  time,  0.25  ml  or 0.5  ml  of culture 
supernate were removed from individual wells and titrated for hemagglutinin. In general, no 
measurable hemagglutinin was detected in cultures not showing CPE. 
Virus Challenge of Experimental Animals.  TURH:  0.5  ml  of  virus  dilutions  in  PBS  were 
inoculated i.p. Deaths due to liver necrosis (9)  were recorded.  Blood and livers from infected 
animals were collected and titrated  for TURH  infectivit~ as previously described  (9).  NWS: 
0.03 ml of A/J brain extract diluted in PBS to contain 10'  LDs0 were inoculated i.c. into mice 
under ether anesthesia. Animals were observed for  14 d. Deaths occurring from the 3rd to the 
8th d after inoculation were recorded as the result of neurotropic influenza infection (2). HKH." 
0.1  ml  of  serial  10-fold  virus  dilutions  in  PBS  were  inoculated  dropwise  i.n.  into  mice, 
anesthesized  with  ether  as described  (1).  Deaths  occurri.ng within 24  h  of inoculation were 
discounted.  Inspection was  carried out  daily thereafter.  On  day  14, all surviving mice were 
killed and the degree of gross pulmonary consolidation was scored. 
Histology.  Liver sections were fixed in 10% neutral formalin. Routine paraffin sections were 
prepared and stained with hematoxylin and eosin (HE). 
Serum Globulin Preparations.  The methods of preparation, partial purification and assay have 
been previously described  (6).  The following globulin preparations were  used:  (a)  AIF from 
sheep No.  1. Its neutralizing titer was  1.2  ×  10  -6 against 8 U  of mouse interferon induced by 
Newcastle disease virus in mouse C-243 cells. (b) Normal sheep serum globulin (NSG). (c) Anti- 
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(12). The human-interferon neutralizing titer was 3  ×  10  -5 and its mouse-interferon neutral- 
izing titer was 1 ×  10  -1. (d) The globulin fraction (ACN) from a sheep No. 11 immunized with 
contaminants  present  in  the  partially 1purified  mouse  interferon  preparations.  It  did  not 
neutralize mouse interferon at  1 ×  10-. For the in vivo experiments, globulin preparations 
were diluted  1:3 in  PBS.  Mice were injected  once i.v. with 0.1  ml immediately before virus 
challenge unless stated otherwise in the text. For the in vitro experiments, the various globulin 
preparations were diluted in culture medium containing 15% FCS to give the desired  concen- 
trations as stated in the text. 
Interferon.  Mouse interferon was assayed by inhibition of CPE on mouse L cells infected 
with vesicular stomatitis virus (13). 
Results 
Effect  of AIF on  the  Course of Myxovirus  Hepatitis  in Mx-Bearing  Mice.  TURH  is  a 
hepatotropic influenza virus strain causing liver necrosis and death within  3-4 d  in 
susceptible adult  mice (9).  We have previously shown that  inborn resistance of Mx- 
carrying mice towards lethal infection with TURH  virus could not be abrogated by 
various  treatments  leading  to  immunosuppression  or  macrophage damage  (3).  To 
check the possible involvement of interferon in the resistance mechanism, groups of 
susceptible A/J  mice or resistant  animals homozygous (A2G)  or heterozygous (A/J 
x  A2G)F1  for  the  resistance  gene  Mx  were  injected  i.v.  with  various  globulin 
preparations before i.p.  challenge  with  graded  doses of TURH  virus. The globulin 
fractions were  (a)  NSG,  (b)  AHI,  (c)  ACN,  and  (d)  AIF. Virus  infected,  untreated 
mice were included as further controls. 
Mortality.  Mortality in AIF-treated Mx-carriers was  100%  for all challenge  doses 
used  and  equaled  that  of  treated  or  untreated  susceptible  A/J  mice  (Table  I). 
Untreated  resistant  mice  and  resistant  mice  inoculated  with  the  other  globulin 
fractions all survived. Onset of death in AIF-treated Mx-bearing animals (especially 
in heterozygous F1 hybrids) was comparable to that in susceptible control A/J mice. 
AIF, but not the other globulin preparations, further decreased the short life span of 
A/J mice injected with  100 lethal virus doses. 
Virus Replication.  TURH  grows to high  titers  in  the  liver of infected susceptible 
animals and causes viremia (9).  Infectivity titers of whole blood samples and of liver 
homogenates from susceptible or resistant  donors infected and treated with NSG or 
AIF 48 h previously were compared (Table II). Equal amounts of infective virus were 
found  in  organs  from both  groups  of A/J  mice irrespective of globulin  treatment. 
Virus content  in  samples from AIF treated Mx-carriers was similarly high and was 
103-106 times greater than in organs from NSG-treated resistant mice. 
Comparative Interferon Production.  Interferon titers in sera from susceptible or resistant 
mice injected i.v. with infectious TURH  virus were determined (Table III). Injection 
of  103  LLDs0  led  to  a  measurable  response  in  A/J  but  not  in  A2G  mice.  Serum 
interferon levels most likely reflected rapid viral multiplication in the susceptible host 
in  contrast  to  decreased  viral  multiplication  in  Mx-carriers.  These  findings  are  in 
agreement with previous data showing that interferon production in organs of infected 
A2G mice was much lower than in the organs of A/J mice (4). 
Pathology.  The livers from viral-infected A2G mice treated  with  NSG,  ACN,  or 
AHI were macroscopically normal. There were a  few small foci of mononuclear cell 
infiltration  (Fig.  1 A).  In  contrast,  the  livers  from  infected  AIF-treated A2G  mice 
were  enlarged  and  friable  as  a  result  of widespread  liver  cell  necrosis  (Fig.  1 B). 
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TAnLE  I 
Abrogation of lnborn Resistance to Hepatotropic Influenza A/Turkey/England 63 by AIF 
Exp. No. 
Mouse 
Strain  Genotype  Treatment[[ 
Virus dose*  Mortality$  Death§ 
I  A/J 
LDso 
( + / + )  None  104  4/4  2(4) 
AIF  104  4/4  2  (4) 
NSG  102  4/4  3 (4) 
AIF  102  4/4  2  (4) 
(A X  A2G)FI  (Mx/+)  None  104  0/4 
AIF  104  4/4  2  (4) 
NSG  102  0/4 
AIF  10  ~  4/4  3  (4) 
A2G  (Mx/Mx)  NSG  104  0/4 
AIF  104  4/4  2 I1), 
None  102  0/4 
AIF  10  2  4/4  3 (3), 
A/J  ( + / + )  NSG  10  a  4/4  2(a), 
AHI  I0  s  4/4  2  (2), 
ACN  10 3  4/4  2 ('), 
AIF  10  s  4/4  2  (4) 
(AxA2G)F1  (Mx/+)  NSG  10  3  0/4 
AHI  10  3  0/4 
ACN  10  3  0/4 
AIF  10  3  4/4  2 (x), 
A2G  (Mx/Mx)  NSG  103  0/4 
AHI  103  0/4 
ACN  10  a  0/4 
AIF  10  a  4/4  3  (3), 
3  (2), 5(11 
6(1) 
3(1) 
3(~) 
3(a) 
w 
3(3) 
4(1) 
* 0.5 ml TURH diluted in PBS was inoculated i.p. 
$ No. of dead animals on day 7/total No. of mice inoculated. 
§ Number indicates day of death after infection. Exponent is No. of mice dying on that day. 
H  Sera were given i.v. immediately before virus challenge (Materials and Methods). 
TABL~  II 
TURH Replication in AIF-Treated Mice * 
EIDs0 (log 10/ml) 
Sample  Mouse strain  NSG-treated mice  AIF-treated mice 
10 2 LD~o  10  4 LDso  10  2 LD~o  10  4 LDso 
Bloods  A/J  6.1  6.0  6.6  6.0 
(A ×  A2G)F1  3.5  3.5  6.4  6.5 
A2G  3.0  3.7  6.5  6.3 
Liver homogenate§  A/J  9.5  ND  8.5  ND 
(A  x  A2G)F~  5.0  5.3  9.0  9.5 
A2G  2.0  4.0  8.0  7.7 
* Injected i.v. with NSG or AIF immediately before i.p. challenge with 102 or 104 LDs0 of TURH. 
$ Heparinized blood pooled from 5 mice per group 48 h after infection. 
§ Prepared from individual livers 48 h after infection. 
II ND  =  not done. HALLER, ARNHEITER,  GRESSER, AND LINDENMANN 
TABLE III 
Comparative Serum Interferon Titers in TURH-Infected Mx-Bearing and 
Control Mice* 
Mouse strain and genotype 
Serum  (A ×  Virus dose i.v.  sample  A/J (+/+)  A2G)F1  A2G (Mx/ 
(Mx/+)  Mx) 
h 
10  s LDso  6  1:40  1  :  30  1  :  20 
18  1:320  1:120  1:160 
10  a LD~0  6  <1:20  <1:40  <1:20 
18  1:480  <1:20  <1:20 
* Pools of serum from four mice (7- to 9-wk-old males). 
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distribution  as  in  livers  from  treated  or  untreated  A/J  mice  (not  shown).  As  a 
consequence of liver cell destruction, liver-specific F antigen  (9) could be detected in 
the sera of these mice (data not shown). No pathological changes were found in AIF 
treated, uninfected control mice. 
Abrogation of Inborn Resistance  towards Neurotropic and Pneumotropic Strains  of Influenza 
Virus by AIF.  Genetically determined resistance towards myxoviruses has been shown 
to manifest  itself in brain and lung to a  similar extent as in  the liver (1-5).  If AIF 
treatment interfered with an element of general importance for the resistance mech- 
anism  this  treatment  should  also  overcome  in  vivo  resistance  to  neurotropic  and 
pneumotropic virus strains. 
INTaACERZBWL CHALLENGE.  A/J mice usually die between the 3rd and 8th d after 
NWS-virus  challenge  (2).  AIF-treated  Mx-bearing  mice  (together  with  treated  or 
untreated A/J controls) infected i.c. with NWS virus succumbed within that period. 
NWS virus was not lethal for untreated homozygous resistant mice (Table IV). One 
untreated heterozygous F1 mouse died on day 9. 
INTaANASAL CHALLENOE.  AIF given i.v. severely impaired resistance of A2G mice 
towards i.n. infection with pneumotropic HKH virus (Fig. 2).  Death was accelerated 
in AIF-treated susceptible mice in comparison to controls after i.n. infection with  104 
LDs0 (Fig.  2) or  102 LDso of HKH  (mean survival time 7.6  d  in AIF-treated mice as 
compared to 9 d in untreated controls). On day 14, surviving animals were sacrificed, 
the degree of lung consolidation was scored, and serum antibody titers against HKH 
hemagglutinin were determined. Pulmonary lesions were much more pronounced and 
HAI titers were approximately four times higher in AIF-treated mice (both A2G and 
A/J)  than in control mice suggesting increased virus replication in these animals. 
In conclusion, the influence of AIF on resistance against i.n. infection was clear-cut 
but less dramatic than that observed on resistance towards infection with neurotropic 
or  hepatotropic  virus  strains,  presumably  because  of the  relative  inability  of the 
globulin to reach the tracheobronchial epithelium as previously discussed  (14). 
Resistance  of Peritoneal Macrophages  Obtained from  Mx-Bearing  Mice and Infected  in  the 
Presence of AIF In  Vitro.  It has previously been shown that peritoneal macrophages 
from genetically resistant  mice express resistance towards infection in vitro with the 
macrophage-adapted  influenza  virus  strain  M-TUR  (2).  Attempts  to  increase  the 
growth potential of M-TUR in resistant  macrophages by serial passages have so far 
failed (2).  We therefore determined whether addition of AIF to resistant macrophage 606  INTERFERON-DEPENDENT  INBORN  RESISTANCE TO INFLUENZA VIRUS 
FIG.  1.  Liver  sections from resistant A2G mice 48 h after i.p. inoculation of 10" LD~0 (as estimated 
in  A/J  mice) of TURH  virus. (A)  NSG  treatment:  focal lesions with  marked inflammatory 
infiltrates. (B) AIF treatment: widespread liver  cell necrosis. Hematoxylin and eosin, X 160. 
cultures  at  the  time  of virus  challenge  would  render  these  cells  susceptible.  One 
representative experiment (out of 4)  is summarized in Table V, showing that  virus 
resistance of Mx-carrying macrophages was  preserved  despite  the  presence of AIF. 
Even  10  times higher AIF concentrations did not  abolish resistance. No cytopathic 
effect was ever seen in such cultures during the usual  1-wk observation period. The TABLE  IV 
Abrogation of lnborn Resistance to Neurotropic Influenza A  Virus NWS by 
AIF 
Mouse 
Strain  Genotype  Treatment§ 
Mortality*  Death~ 
d 
A/J  (+/+)  None  6/6  3 I1), 4 ~4), 7  ") 
AIF  4/4  3 I*) 
(A  X  A2G)F1  (Mx/+)  None  1/5  9 ~1) 
AIF  4/4  5 (2), 6 (a~, 8 (1) 
A2G  (Mx/Mx)  None  0/4  -- 
AIF  4/4  4 ~l~, 6 ~2), 7  ~l) 
* No. of dead animals on day  14/total No. of mice inoculated. 
* Number indicates day of  death after infection. Exponent is No. of  mice dying 
on that day. 
§ AIF was given i.v.  15 min before i.e. challenge with  l02 i.e. LD~o of NWS. 
Fla.  2.  Effect of AIF  treatment  on  intranasal  infection with  pneumotropic influenza A/Hong 
Kong/1/68.  Groups of five mice were challenged i.n. with  virus and were injected i.v. with AIF 
(solid bars) or left untreated (open bars). A  ~  A2G,  104 LDs0 i.n., B  ffi A2G,  105 LD~o i.n., C  --- A/ 
J,  104 LDs0 i.n. 
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TABLE  V 
Resistance of Peritoneal Macrophages  from Mx-Bearing Mice to Infection with M-TUR in the Presence  of 
AIF In Vitro 
Macrophage*  Hemagglutination titers of culture supernate§ 
M- 
TUR:I:  AIF-treated cuhuresl[  NSG-treated cultures¶ 
Culture  TCIDs0  Time after infection  Time after infection 
Origin  No.  (log  10) 
48  72  168  48  72  168 
h  h 
A/J  1  6  1:512  >1:1024  ND  1:512  >1:1024  ND 
2  5  1:256  >1:1024  ND  1:128  >1:1024  ND 
3  4  1:16  >1:1024  1:1024  1:8  >1:1024  1:512 
4  4  1:8  >1:1024  1:1024  ND 
5  3  0  >1:1024  ND  0  >1:1024  ND 
(A  X  6  6  1:16  1:16  1:8  1:8  1:4  1:4 
A2G) F1  7  5  1:2  1:8  1:4  0  0  0 
8  4  0  1:8  1:2  0  0  0 
9  4  0  0  1:2  ND 
10  3  0  0  0  0  0  0 
A2G  11  5  1:8  1:8  1:2  0  0  0 
12  4  0  1:4  1:2  ND 
* Pooled from five mice per group and kept for 22 h in culture before virus challenge. 
$ 0.2  ml of 10-fold virus dilutions in culture medium were added to 1.8 ml of culture medium containing 
AIF or NSG. Input virus was not removed. 
§ 0.25 ml/well of culture medium was removed and titrated for hemagglutinin using twofold dilution steps. 
0 indicates no hemagglutination of 1:2 dilutions. 0.5 ml of fresh medium (representing 1/4 of total volume) 
was added to each well on day 4. 
II AIF was added before virus infection and was present during the entire experiment at a dilution of 10 -3 
corresponding to a neutralizing titer of 1.2  ×  10  -3 against 8 U of interferon. 
¶ NSG was added before virus infection and was present during the whole experiment at a dilution of 10  -3. 
small amounts of hemagglutinin  in the supernates of AIF-treated resistant  cultures 
may reflect in part the input virus. 
Virus Susceptibility of Macrophages Taken from  AIF  Treated Mx-Carrying Donors and 
Maintained in the Presence of AIF.  Resistance of macrophages and in vivo resistance of 
the whole animal have previously been shown to be correlated (2). Because treatment 
of mice with  AIF  abolished  resistance  to  influenza  virus, we  determined  the  virus 
susceptibility  of  macrophages  obtained  from  AIF-treated  donors  (Table  VI).  As 
expected, macrophages from NSG injected or untreated A2G mice were resistant even 
in  the  presence of AIF.  In contrast,  M-TUR  grew well  in  macrophages from AIF- 
treated A2G mice, provided AIF was also present in vitro at the time of virus infection. 
Virus multiplying in such A2G cultures was identified as M-TUR by hemagglutina- 
tion  inhibition  tests  using  antisera  of known  specificity.  It  was  noninfectious  for 
ordinary A2G macrophages but attained  high titers  (107 TCIDs0/ml) in susceptible 
A/J macrophage cultures. 
Discussion 
It has long been assumed that interferon plays an important role in host defense in 
viral infections. Thus, Isaacs and I-Iitchcock (15) stated that interferon was formed at 
the right place and at the right time to influence virus infection in vivo. Nevertheless, HALLER,  ARNHEITER,  GRESSER,  AND  LINDENMANN  609 
TABLE  VI 
Susceptibility of Peritoneal Macrophages from AIF-Treated A2G Mice to Infection with M-TUR 
Exp. No. 
Mouse  Macro-  M-  Type of§  Virus growthl] 
phage  TUR:}:  globulin  48 h  72 h 
In vivo*  culture  l0  s  added in 
Strain  treat-  No,  TCIDs0  vitro 
ment  CPE  HA titer  CPE  HA titer 
A2G  AIF  1  +  NSG  +  1:16  ±  1:8 
2  +  NSG  ±  1:32  ±  1:4 
3  +  AIF  +  +  1:512¶  +  +  +  1:256 
4  +  AIF  +  +  1:256  +  +  +  1:64 
5  +  AIF  +  +  1:256  +  +  +  1:128 
6  -  AIF  -  0  -  0 
A2G  NSG  7  +  NSG  -  0  -  0 
8  +  AIF  -  0  -  0 
9  +  AIF  -  0  -  0 
AIF  I0  +  NSG  -  0  -  0 
i I  +  NSG  -  0  -  0 
12  +  AIF  +  I:160  +  +  1:160 
13  +  AIF  +  1:80  +  +  1:160 
None  14  +  AIF  -  1:2  -  1:2 
15  +  None  -  0  -  0 
A/J  None  16  +  NSG  +  +  1:160  +  +  +  1:320 
17  +  None  +  +  1:160  +  +  +  1:160 
* Three mice per group were injected i.v. with 0.2 ml (exp.  1) or 0.1 ml (exp. 2) of a  1:3 dilution of AIF or 
NSG 24 h  (exp.  1) or 3 h (exp.  2) before stimulation by i.p. injections of thioglycollate medium. 
:~ Macrophages  were  infected after a  20-h culture  period.  +,  infected cultures;  -,  uninfected control 
cultures. Input virus was not removed. 
§ Sheep anti-mouse interferon globulin (AIF)  or normal sheep globulin (NSG)  at  10  -a dilutions giving 
neutralizing titers of AIF of 1.2  ×  10  -3 were added to culture wells either immediately (exp.  I) or  16 h 
(exp. 2) before virus challenge and were kept present throughout the experiments. 
]l Assessed by cytopathic effects (CPE: -, none; ±, tiny; +  moderate;  +  +  pronounced; +  +  +  total) and 
hemagglutinin (HA) titers of culture supernatants. 0.5 ml/well were removed at the times after infection 
indicated and replaced by fresh medium (representing V4 of total volume). 0 indicates no hemagglutination 
at a dilution of 1:2. 
¶ Hemagglutination inhibition with a standard rabbit antiserum directed against A/Turkey/England/63 
was positive. This A2G culture supernate was infectious for susceptible A/J macrophages but not for 
A2G macrophages. 
the evidence  for  the role of interferon has been  indirect, based  for the most  part  on 
temporal  associations between  the presence of virus and interferon in different tissues. 
Recent  work,  however,  using antibody  to mouse  interferon has provided  more direct 
evidence  for the beneficial role  of interferon in  the initial response  to viral  infection 
(6,  7,  14,  16,  17).  We  have shown  herein that  interferon is an integral and  important 
part  of the inborn  resistance to  influenza virus in mice determined  by the gene Mx. 
Thus, anti-interferon globulin  (AIF) increased susceptibility of A2G mice to the lethal 
action  of influenza  A  virus >  100-fold.  This  abrogation  of resistance in AIF  treated 
mice  was  manifested  in  varying  degrees  with  all  virus  strains  tested,  neurotropic, 
pneumotropic,  and  hepatotropic. 
We  had  previously  shown  that  macrophages  from  mice  bearing  the  Mx  gene 
expressed  resistance  in  vitro  (2),  and  that  a  direct  correlation  existed  between  the 
resistance of an individual  mouse to influenza virus and the in vitro resistance of that 
mouse's macrophages  (2). In the experiments  reported herein, it was found that when 
macrophages  were  taken  from  mice  treated  with  AIF,  and  then  cultivated  in  vitro 610  INTERFERON-DEPENDENT INBORN RESISTANCE TO INFLUENZA.  VIRUS 
with AIF, they were fully susceptible to influenza virus, and capable of producing as 
much  virus  as  macrophages  from susceptible  mice  (Table VI).  Treatment  of mice 
with AIF followed by omission of AIF in vitro (Table VI) or, conversely, cultivation 
of resistant  macrophages with AIF (from a  mouse not treated with AIF)  (Table V) 
failed  to  convert  resistant  macrophages  into  susceptible  macrophages.  Although 
virtually all work on interferon to date suggests that interferon is an induced protein, 
the  findings just  mentioned  imply  the  possibility  of the  existence  of endogenous 
interferon in mice. In support of this possibility it may be mentioned that rabbit (18) 
and mouse macrophages (19)and human leucocytes (20) have been shown to liberate 
interferon  spontaneously  into  the  culture  medium.  If macrophages  for  example 
produced  small  amounts  of interferon  in  vivo and  in  vitro,  this  would  explain  the 
necessity of treatment  of mice with  AIF as well  as the  maintenance  of AIF in  the 
culture  medium.  More  recently,  however,  we  have  found  that  macrophages  from 
resistant  mice can be converted  to susceptibility even  in  the  absence of AIF, after 
cultivation  in  vitro  for  2  wk.  Perhaps  endogenous  interferon  acts  on  peritoneal 
macrophage in vivo and this effect gradually wanes in vitro. 
Whether  we suggest  greater amounts  of interferon  before or after infection  with 
influenza virus, or greater sensitivity to interferon in A2G mice than in A/J mice, we 
are nevertheless obliged to explain the specificity of this resistance for influenza virus. 
Therefore, if interferon is implicated as the experiments with AIF indicate, why are 
A2G mice selectively resistant to influenza virus and not also resistant to other viruses? 
In fact, A2G mice are as sensitive to several other viruses as are control  mice  (21). 
Likewise, other strains of mice show varying levels of specific resistance to flaviviruses 
(22,  23)  and  mouse  hepatitis  virus  (7).  We  should  like  to  suggest  the  following 
hypothesis to explain  the resistance of A2G mice to influenza virus. The interferon 
produced  (either  spontaneously  or  upon  induction)  is  more effective in  protecting 
A2G macrophages (and possibly also other cells) against influenza virus than it is in 
protecting A/J mouse cells against influenza virus. In other words, we are suggesting 
that  there  is  a  genetically  determined  difference  between  strains  of mice  in  this 
sensitivity to interferon which  is specific for a  given group of viruses. In the case of 
A2G mice, we would  suggest that  a  threshold  amount  of interferon  renders  certain 
A2G mouse cells resistant to influenza virus, whereas the same amount is insufficient 
to protect A/J mouse cells against  the same challenge.  Interferon would  be equally 
effective in  protecting A2G and A/J  mouse cells against  infection with  some other 
viruses. Although we have no clear cut evidence to support this hypothesis yet, which 
has also been discussed with regard to flaviviruses (22), it is of interest that a similar 
finding is obtained for cells derived from different species. Thus, the relative sensitiv- 
ities of viruses to interferons were found to be characteristic of the species tested. For 
example, vaccinia virus was the  most sensitive of five viruses when  tested  in  mouse 
and hamster cells, but the least sensitive when tested in human, rabbit, and bat cells 
(24).  In  another  study,  pseudorabies  and  vaccinia  viruses  were  as  susceptible  as 
vesicular stomatitis virus to inhibition by interferon when tested in chicken or mouse 
cells  but  were  refractory  to  inhibition  in  interferon-treated  rabbit  cells  (25).  The 
authors suggested that separate resistance factors might exist in interferon treated cells 
for DNA and RNA viruses, and that certain interferon-treated rabbit cells could not 
generate resistance factors for some DNA viruses (25).  Our hypothesis implies that a 
similar  hierarchy  of response  to  interferon's  effect  as  regards  a  given  virus  varies HALLER, ARNHEITER,  GRESSER, AND LINDENMANN  611 
within the species (i.e., the mouse in our experiments). If this phenomenon existed it 
would imply not only that individuals varied in their sensitivity to interferon (which 
might  be  expected)  but  that  the  enhanced  or  decreased  sensitivity  might  also  be 
manifested for a  specific virus. Furthermore, because genes like Mx could, in certain 
tissues, be temporarily or permanently switched off, this might explain some puzzling 
tissue tropisms. 
Rather  than  viewing interferon  as  the primary factor in  the  anti-viral state and 
assuming  its  modulation  by  host  genes,  we  could  also  consider  interferon  as  an 
auxiliary necessary for the expression of a  genetically determined cellular resistance. 
According to this hypothesis, the inherent resistance of Mx-bearing cells, whatever its 
mechanism,  would  be  the  major  component  of resistance.  Removal  of interferon 
however creates an artificial situation in which resistance can no longer be expressed 
efficiently. In any case, the intimate cooperation of interferon with the genetic make 
up  of the  host  as  revealed  by  our  experiments  promises  deeper  insights  into  the 
complexities of antiviral defense mechanisms. 
Summary 
The genetically determined resistance towards orthomyxoviruses exhibited by mice 
homozygous (A2G) or heterozygous (A2G  ×  A/J)  for the gene Mx was abolished or 
greatly diminished  by treatment  with  anti-interferon  globulin  (AIF).  AIF induced 
increased  susceptibility  to  challenge  with  hepatotropic,  neurotropic,  and  pneumo- 
tropic strains  of influenza  A  virus.  Hepatotropic virus titers  in  blood and  livers of 
AIF-treated,  Mx-bearing  mice  were  higher  by  a  factor  of  103-10  ~ than  those  in 
untreated  mice of the same genotype, and were comparable to those in genetically 
susceptible (untreated or AIF-treated) mice. 
Peritoneal macrophages from Mx-bearing untreated mice were resistant to challenge 
with a  macrophage-adapted strain of influenza A  virus even in the presence of AIF. 
However, when macrophages were taken from resistant  mice injected with AIF and 
also  cultivated  in  the  presence  of AIF,  they  were  as  susceptible  to  the  virus  as 
macrophages taken from susceptible mice. We conclude that interferon is an important 
factor in resistance to orthomyxoviruses governed by the gene Mx. 
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